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Abstract
Background: The four highly homologous human EHD proteins (EHD1-4) form a distinct
subfamily of the Eps15 homology domain-containing protein family and are thought to regulate
endocytic recycling. Certain members of this family have been studied in different cellular contexts;
however, a lack of concurrent analyses of all four proteins has impeded an appreciation of their
redundant versus distinct functions.
Results: Here, we analyzed the four EHD proteins both in mammalian cells and in a cross-species
complementation assay using a C. elegans mutant lacking the EHD ortholog RME-1. We show that
all human EHD proteins rescue the vacuolated intestinal phenotype of C. elegans rme-1 mutant, are
simultaneously expressed in a panel of mammalian cell lines and tissues tested, and variably homo-
and hetero-oligomerize and colocalize with each other and Rab11, a recycling endosome marker.
Small interfering RNA (siRNA) knock-down of EHD1, 2 and 4, and expression of dominant-
negative EH domain deletion mutants showed that loss of EHD1 and 3 (and to a lesser extent
EHD4) but not EHD2 function retarded transferrin exit from the endocytic recycling compartment.
EH domain deletion mutants of EHD1 and 3 but not 2 or 4, induced a striking perinuclear clustering
of co-transfected Rab11. Knock-down analyses indicated that EHD1 and 2 regulate the exit of cargo
from the recycling endosome while EHD4, similar to that reported for EHD3 (Naslavsky et al.
(2006) Mol. Biol. Cell 17, 163), regulates transport from the early endosome to the recycling
endosome.
Conclusion: Altogether, our studies suggest that concurrently expressed human EHD proteins
perform shared as well as discrete functions in the endocytic recycling pathway and lay a foundation
for future studies to identify and characterize the molecular pathways involved.
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Endocytosis is an essential cellular process that regulates
the delivery of specific cargo and lipid membranes to
appropriate subcellular destinations [1]. Endocytic traffic
of signaling receptors into lysosomal versus recycling
endosomal pathways also provides a fundamental mech-
anism to control cellular responses to environmental
changes. Finally, the endocytic pathway intersects other
intracellular transport pathways such as the secretory
pathway. Understanding the molecular basis of regulated
transport within the endocytic pathway is, therefore, of
broad interest and substantial biological significance.
Protein-protein interactions provide a central mechanism
to control cellular functions, and regulatory proteins
within a given functional pathway are often characterized
by the presence of related modular protein-protein inter-
action domains. A large subset of proteins involved in the
regulation of endocytic trafficking events contain an
Eps15 Homology (EH)1 domain, first identified as three
repeated copies in the epidermal growth factor receptor
pathway substrate 15 (Eps15) [2,3]. There are over 50 EH
domain-containing proteins known [4] and many of
them, such as Eps15, Eps15R, intersectin, POB1, END3
and REPS1, are involved in the early stages of endocytosis
[5]. EH domains recognize an Asn-Pro-Phe (NPF) motif
within target proteins to assemble protein complexes that
function at various steps during endocytic traffic, such as
cargo selection and formation of clathrin-coated pits at
the plasma membrane [6].
The recently identified subfamily of EH domain-contain-
ing proteins (EHD1-4) are characterized by a unique
domain organization distinct from other EH domain-
bearing proteins: they contain a single EH domain at the
C-terminus, a central coiled-coil region and a phosphate-
binding loop (P-loop) capable of binding nucleotides in
the N-terminal region [7-9]. The genes encoding these
proteins are located on different chromosomes, EHD1 on
11q13 [7], EHD2 on 19q13.3, EHD3 on 2p21 and EHD4
on 15q11.1, yet they share a high degree of homology at
the nucleotide and amino acid levels [8]. The presence of
four EHD proteins in mammals appears to reflect recent
duplications as a single gene is found in non-mammalian
organisms [8].
The presence of an EH domain suggests a possible role for
these proteins in receptor-mediated endocytosis. Consist-
ent with this idea, mutations in receptor-mediated endo-
cytosis-1 (RME-1, the only C. elegans homolog) led to
defective endocytic traffic of the yolk protein receptor
RME-2 as well as aberrant trafficking in intestinal cells
leading to a vacuolated intestine phenotype in C. elegans
[10]. RME-1 is most closely related to human EHD1 [10]
and it has been shown that EHD1 is involved in the recy-
cling of a variety of receptors from the endocytic recycling
compartment (ERC) to the plasma membrane [11-14].
Previous studies have also shown that EHD1 and 3 reside
in the ERC as indicated by their colocalization with trans-
ferrin [11,15]. Furthermore, perturbations of EHD1 and 3
led to altered distribution and function of the ERC
[11,16]. Other EHD proteins have been studied in special-
ized cells such as adipocytes and pheochromocytoma
cells. EHD2 was isolated from GLUT4-enriched fractions
of adipocytes and shown to regulate insulin-mediated
translocation of GLUT4 to the plasma membrane [17,18].
EHD4, also called Pincher, has been shown to regulate
neurotrophin receptor TrkA endocytosis in pheochromo-
cytoma (PC12) cells [19].
Several EHD-binding proteins have been identified
recently such as Rabenosyn-5 [12], SNAP29/GS32
[20,21], syndapin I and II [20,22], α-adaptin subunit of
AP2 [21], reticulon (in the case of RME-1) [23], Rab11-
FIP2 [16], EHBP1 [17,24] and Numb [25]; many of these
contain one or more NPF motifs [26]. Biochemical studies
and yeast two-hybrid experiments have shown that muta-
tions in the P-loop and coiled-coil region interfere with
oligomerization of RME-1/EHD1 [9] and EHD3 [16].
Despite the emerging information on their role in endo-
cytic recycling of different receptors and identification of
their interaction partners, little is known about EHD pro-
teins and how they function in cells.
While these initial studies have begun to establish the role
of EHD proteins in endocytic traffic, in particular at the
ERC, there has been a distinct lack of biochemical and
functional comparisons of mammalian EHD proteins in a
single cellular system. As suggested by Naslavsky and Cap-
lan, the overall identity of EHD proteins is slightly higher
than that of their EH domains [27] and the comparison of
all human EHD proteins in parallel could, therefore, pro-
vide important clues to their function in mammalian
cells. Here, we have compared the four human EHD pro-
teins with respect to their expression, localization and
function to identify their distinct and shared cellular func-
tions. These studies, together with recent comparison of
EHD1 and 3 by the Caplan group [16], should serve as a
basis for further efforts to understand the molecular basis
of EHD protein function.
Results
The four mammalian EHD proteins are highly related in
sequence as well as domain structure [8,27]. However, it
is not clear whether they have distinct roles in mamma-
lian cells, perform similar function in different cellular
contexts or are, to some degree, redundant in function. To
begin to address these issues, we have carried out simulta-
neous biochemical and functional analyses of human
EHD1-4 both through reconstitution of function in the C.Page 2 of 22
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ortholog RME-1 is mutated, and by expression in mam-
malian cells.
All human EHD proteins rescue the defective rme-1 
function in the intestine of C. elegans rme-1(b1045)
The role of EHD proteins in endocytic recycling was first
revealed by the isolation of C. elegans EHD ortholog RME-
1 as a regulator of endocytosis [10,11]. Among the various
defects, rme-1 mutants were shown to develop large vacu-
oles in the intestine at the larval L4 stage which increased
in number with age. These vacuoles accumulate fluid
phase markers within minutes of application to the baso-
lateral surface, but not when applied to the apical surface,
indicating that they arise from a specific basolateral traf-
ficking defect [28]. RME-1 is most closely related to mam-
malian EHD1, and GFP-RME-1 and -EHD1 formed
similar vesicular structures and colocalized with transfer-
rin in Chinese Hamster Ovary (CHO) cells [11]. Given the
overall conservation among mammalian EHD proteins,
we used mutant C. elegans with anon-functional EHD
ortholog in a cross-species complementation strategy to
test if all or selected human EHD proteins function to reg-
ulate endocytic trafficking.
Since the deletion mutant allele rme-1(b1045) (deletion of
entire coding region from codon 240 onwards) was
shown to lack any detectable RME-1 protein and did not
appear to be dominant-negative [10], we chose this allele
for our rescue experiments. The vacuolated intestinal phe-
notype is a suitable assay system since it is easy to score
and has been successfully used to identify a novel gene
involved in endocytic recycling in intestinal cells [29]. The
human EHD cDNAs were cloned into an expression vec-
tor driven by the intestine-specific Vha-6 promoter [30]
with an IRES sequence separating the EHD gene from the
coding sequence of a GFP marker. This allowed easy scor-
ing of the vacuoles as circular regions devoid of green flu-
orescence (Figure 1A, arrows). Similar to the rme-
1(b1045) animals, which had an average of 21 ± 1.2 vacu-
oles per animal, GFP-expressing transgenic rme-1(b1045)
animals (vector) had an average of 23 ± 1.3 vacuoles per
animal (Figure 1B). Wild type (N2 Bristol) animals never
developed intestinal vacuoles. As expected from the close
structural similarity with RME-1, expression of human
EHD1 was able to rescue the vacuolated intestinal pheno-
type comparable to that observed with prme-1::GFP-RME-
1 construct (0.8 ± 0.4 vacuoles per animal, Figure 1B)
[10]. Notably, we observed that the other human EHD
proteins could also rescue the intestinal phenotype to an
extent comparable to that seen with EHD1 (Figure 1B). To
further examine the rescue of the basolateral trafficking
defect, we injected the fluid phase marker Texas Red-BSA
(TR-BSA) into the psuedocoelom. The TR-BSA accumu-
lated within one minute of injection in the intestinal vac-
uoles of rme-1(b1045) animals (Figure 1C, left). In wild
type animals, no accumulation of TR-BSA was observed
reflecting the efficient recycling back to the pseudocoelom
of the basolaterally endocytosed fluid phase markers (Fig-
ure 1C, middle) [28]. As expected, rescued rme-1(b1045)
animals did not accumulate any TR-BSA similar to wild
type animals, indicating that the basolateral trafficking
defect was rescued in these worms (Figure 1C, right).
When TR-BSA was presented via the apical surface using
feeding, it did not accumulate in the vacuoles in either the
mutant or the rescued worms indicating that apical endo-
cytosis and recycling were unaffected in these worms (data
not shown). Collectively, these experiments indicate that
human EHD proteins retain the basic function of their C.
elegans ortholog to control endocytic trafficking.
All human EHD proteins are concurrently expressed in 
multiple cultured cell lines and several tissues
Rescue of defective endocytic recycling in mutant worms
by all human EHD proteins strongly suggested that these
proteins might participate in regulation of the endocytic
pathway in mammalian cells. The emergence of multiple
RME-1 orthologs (EHD1-4) in higher mammalian organ-
isms could reflect tissue-specific expression or further
functional diversification as a result of distinct localiza-
tion or interaction with specific protein partners. There-
fore, we checked whether all EHD proteins or only
selected members are expressed concurrently in a given
mammalian cell. Previously, EHD-encoding mRNAs were
detected in various human tissues [7,8], but concurrent
endogenous EHD protein expression has only been
recently shown for HeLa cells and suggested for normal
mouse fibroblasts [16]. To assess endogenous EHD pro-
tein expression in a broader array of human cell lines, we
developed and characterized rabbit anti-peptide antisera
that specifically recognize individual human EHD pro-
teins based on selective immunoblotting of exogenously
expressed EHD-GFP proteins in HEK 293T cells (Addi-
tional File 1). Western blots of endogenous proteins using
these antibodies demonstrated that each of the 7 selected
human cell lines expressed all four EHD proteins (Figure
2). Analysis of nearly fifteen additional cell lines con-
firmed this general conclusion (data not shown). Endog-
enous EHD proteins were also detected in mouse tissue
extracts using the same antibodies (Figure 3). All EHD
proteins are expressed in most tissues tested, although
their levels varied between tissues. For example, EHD3 is
highly expressed in kidney and brain, whereas, EHD1, 2
and 4 are highly expressed in lung, heart and spleen. Tis-
sue-specific levels of expression may point to differences
in their functions.Page 3 of 22
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All human EHD proteins rescue the vacuolated intestinal phenotype in the intestine of C. elegans rme-1 (b1045)Figure 1
All human EHD proteins rescue the vacuolated intestinal phenotype in the intestine of C. elegans rme-1 
(b1045). (A) Micrograph images of middle intestinal regions of transgenic animals expressing the human EHD proteins. The 
rme-1(b1045) worms were injected with pVha-6::SL2-GFP (50 ng/µl) or with the same construct containing the human EHD 
cDNAs along with myo2::GFP (100 ng/µl) as a co-injection marker. Intestinal vacuoles are viewed as spaces devoid of green flu-
orescence in the rme-1(b1045) mutant (arrows). (B) Intestinal vacuoles were counted in at least 3 independent transgenic lines 
expressing no vector (rme-1(b1045)), vector alone (Vector), or a vector containing EHD1-4. (C) Basolateral endocytosis assay 
of the intestinal vacuoles. Adult hermaphrodites were microinjected with 1 mg/mL Texas-Red BSA (TR-BSA) into the pseudo-
coelom and examined for uptake in intestinal vacuoles. Lack of accumulation of TRed-BSA microinjected into the pseoudoce-
lum in wild-type (WT) worms (N2 Bristol strain) (left). Rapid accumulation of TR-BSA in the enlarged intestinal vacuoles 
(arrows) in the rme-1(b1045) mutant worms (middle). rme-1(b1045) worms rescued with human EHD4 do not display accumu-
lation of the dye in any intestinal cells (right) similar to WT animals. * – pseudocoelom, ** – gonads. DIC – differential interfer-
ence contrast microscopy.
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but EHD2 is relatively deficient in hetero-oligomerization
EHD proteins contain coiled-coil domains thought to be
involved in oligomerization. Yeast two-hybrid interaction
and mammalian cell co-expression studies have demon-
strated the existence of RME-1/EHD1 homo-oligomers
and EHD1/3 hetero-oligomers [9,15,16]. A functional P-
loop and coiled-coil region are required for oligomeriza-
tion and are essential for RME-1 and EHD1 function
[9,16]. No such information is available for EHD2 and
EHD4. One possible means for functional heterogeneity
among EHD proteins could be their differential ability to
form homo- and hetero-oligomers with other EHD pro-
teins in a given cell. In order to assess the ability of human
EHD proteins to form homo- and hetero-oligomers, we
co-transfected Myc- and GFP-tagged EHD proteins in HEK
293T cells and assessed the presence of the EHD-GFP part-
ner in anti-Myc immunoprecipitates. All EHD proteins
formed homo-oligomers when GFP- and Myc-tagged
forms of the same EHD protein were co-expressed (Figure
4A). Furthermore, EHD1 co-immunoprecipitated with
each of the other three EHD proteins both when Myc-
EHD1 was co-expressed with GFP-tagged EHD2, 3 or 4, or
when EHD1-GFP was co-expressed with Myc-tagged
EHD2, 3 or 4. Co-immunoprecipitation (co-IP) of Myc-
EHD4 with GFP-tagged form of itself or EHD1 was always
robust, whereas its co-IP with EHD2- or 3-GFP was always
detectable but varied in extent. The co-IP of EHD2 with
EHD3 or 4 proteins was substantially lower when com-
pared to other oligomeric combinations, indicating that
EHD2 may primarily exist as either a homo-oligomer or a
hetero-oligomer with EHD1 or that it may be present in a
different compartment. Differential co-IP was not due to
differences in the expression of proteins as revealed by
immunoblotting of whole cell lysates (Additional File 2A,
B). Similar results were obtained using HeLa cells (data
not shown). The general pattern of co-IP in homo- and
hetero-oligomeric combinations was similar when Myc-
tagged EH domain deletion (∆EH) mutants of EHD pro-
teins were co-expressed with full-length GFP-tagged pro-
teins (Figure 4B) indicating that the oligomerization of
the human EHD proteins are independent of their EH
domain.
That co-IPs were not due to non-specific interactions of
overexpressed proteins was demonstrated by the lack of
All human EHD proteins are concurrently expressed in multiple cell linesFigure 2
All human EHD proteins are concurrently expressed in multiple cell lines. Aliquots of 100 µg cell lysates were 
resolved by 8% SDS-PAGE and subjected to immunoblotting with rabbit anti-peptide antisera raised against specific EHD pro-
teins. Endogenous EHD proteins were detected in each cell lysate. The specificity of the antisera for EHD proteins is shown in 
Additional File 1 using GFP-fusion proteins. Relative molecular weight (MW) markers are indicated in kiloDaltons (kD). As a 
loading control, β-Actin was blotted.Page 5 of 22
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protein 3 (MTMR3) when co-transfected with Myc-EHD1
and by the lack of co-IP of Myc-sorting nexin-1 (SNX1) co-
transfected with EHD1-GFP (Additional File 2C). When
the primary sequences of human EHD proteins were ana-
lyzed using COILS (a coiled-coil prediction software), we
observed that amino acids 195–228 of EHD1 and 3
showed a strong tendency to form coiled-coils, with lower
scores for EHD2 and 4 (Additional File 3). This is in gen-
eral agreement with our co-IP results. Thus, while all
human EHD proteins are capable of homo- and hetero-
oligomerization, they differ in their choice of oligomeri-
zation partners within the same cellular milieu with pref-
erence for certain homo- and hetero-oligomeric
combinations. Here, we show for the first time using co-
IP analyses that all overexpressed human EHD proteins
form homo- and hetero-oligomers with one another in
mammalian cells. While endogenous co-IPs from cell
lysates have not been successful thus far (data not shown),
possibly due to uneven co-expression, our initial analyses
of mouse tissue extracts using anti-human EHD1 antibod-
ies indeed show co-IP of EHD1 with EHD2 or EHD4 (data
not shown) supporting the likelihood that endogenous
EHD proteins do oligomerize.
Human EHD-GFP proteins localize to tubulovesicular 
structures in HeLa cells
Previous studies have shown that wild type human EHD1
and EHD3 as well as the C. elegans RME-1 protein
expressed in mammalian cells localize to tubulovesicular
endocytic structures that include the ERC, although local-
ization to additional vesicular structures was also noted
[13,15]. Notably, the endocytic localization was com-
pletely lost in the loss-of-function P-loop mutants [9-
11,13]. Therefore, we compared the subcellular localiza-
tion patterns of human EHD proteins within a single cel-
lular background to assess any differences in their
localization. When GFP-tagged human EHD proteins
were transfected into HeLa cells, we observed that EHD1,
3, and 4 were present in pleomorphic tubulovesicular
structures in the perinuclear area, and in some cells these
structures extended toward the periphery (Figure 5A). All
transfected cells showed vesicular structures, but tubular
structures varied greatly in number between cells and were
entirely absent in some cells. A movie of an EHD1-GFP-
transfected cell shows that these structures are dynamic;
this is true of other EHD transfected structures (Additional
File 4). In contrast, EHD2-GFP lacked perinuclear tubular
structures and showed punctate vesicular staining
EHD protein expression in normal mouse tissuesFigure 3
EHD protein expression in normal mouse tissues. An 18 week-old male and female C57BL/6 mouse was sacrificed, 
organs were removed and lysed in tissue lysis buffer as described in Methods. Aliquots of 100 µg tissue lysate were separated 
using 8% SDS-PAGE and a Western blot was performed using antibodies raised against human EHD proteins. The membrane 
was serially stripped and reprobed beginning with both EHD1 and EHD4, followed by EHD2, EHD3 and Hsc70 antibodies. The 
* denotes bands that bled through from the previous blot following stripping. Differential mobility of Hsc70 may represent tis-
sue specific isoforms. Blots shown have exposure times of less than 10 seconds, upon longer exposures, most EHD proteins 
can be seen in each organ shown. Relative molecular weight (MW) markers are indicated in kiloDaltons (kD). As a loading con-
trol, Hsc70 was blotted. M. gland – mammary gland.Page 6 of 22
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In vivo homo- and hetero-oligomer formation of human EHD proteins in mammalian cellsFigure 4
In vivo homo- and hetero-oligomer formation of human EHD proteins in mammalian cells. (A) HEK 293T cells in 
100-mm tissue culture dishes were co-transfected with DNA encoding a single Myc-EHD (2.5 µg) and one EHD-GFP (2.5 µg) 
construct. Cell lysates were prepared 26–30 h after transfection, rocked overnight at 4°C, and 1 mg aliquots of lysate were 
subjected to immunoprecipitation (IP) with 3 µg of anti-Myc (9E10) antibody followed by serial anti-Myc and anti-GFP immuno-
blotting. A negative control (control) using 3 µg of anti-Cbl-b mouse monoclonal IgG1 (lane 9 and 19) was carried out using the 
lysates transfected (*) as in lane 1 and lane 11, respectively. Further negative controls for the specificity of the co-IP are shown 
in Additional File 2C. The identity of the lower bands in lanes 15–18 of the anti-Myc blots are unknown. (B) HEK 293T were 
similarly co-transfected with DNA encoding a single Myc-EHD ∆EH (2.5 µg) and an EHD-GFP (2.5 µg) construct and IPs were 
carried out as above except that lysates were rocked only 1–2 hours at 4°C following lysis. This exception allowed positive 
detection of EHD2 ∆EH co-IPs whereas EHD1 ∆EH results were unaffected with further rocking. The identity of the lower 
bands of the anti-Myc blots in lanes 5–9 and 15–19 are the heavy chain of the mouse IgG (IgH) and are assumed to be masked 
by and comigrating with Myc-EHD1 ∆EH and Myc-EHD3 ∆EH in lanes 1–4 and 11–14, respectively. All blots are representative 
of 3 experiments and the lysates used for these IPs are shown in Additional File 2A–2B. Relative molecular weight (MW) mark-
ers are indicated in kiloDaltons (kD).
BMC Cell Biology 2007, 8:3 http://www.biomedcentral.com/1471-2121/8/3throughout the cytoplasm. In addition, EHD2 was also
observed at the plasma membrane where it often dis-
played a pattern of microspikes (Figure 5A). Comparable
differences between EHD2-GFP and other GFP-tagged
EHD proteins were observed upon transfection of CHO
cells and immortal human mammary epithelial cell line
MCF10A (data not shown).
EHD proteins variably colocalize with each other
We further assessed the colocalization of EHD proteins by
co-expressing their GFP- and DsRed-tagged forms in HeLa
cells. Comparison of GFP- versus the DsRed-tagged ver-
sions of each protein showed that different tags did not
alter their overall patterns of localization, a conclusion
further borne out by co-expressing the two tagged versions
of the same protein (Figure 6). Importantly, EHD1
showed substantial colocalization with EHD3 and 4 and
vice versa. In contrast, EHD2 showed little, if any, colocal-
ization with EHD1 or 3 but showed partial colocalization
with EHD4. Since the expression pattern of individual
tagged EHD proteins did not appear to differ when
expressed individually or with other EHD proteins (with
the exception of the EHD2 and EHD4 pair), it appears
unlikely that overexpression of one protein affects the
expression pattern of the other. In the case of EHD4, we
observed tubular and vesicular structures when it was
overexpressed alone or with EHD1 and 3; however, when
co-overexpressed with EHD2, EHD4 was primarily
observed in larger vesicular structures.
Earlier studies with individual EHD proteins have shown
an important functional role of the EH domain. Overex-
pression of EHD1 G429R, a mutation that is proposed to
alter the conformation of the EH domain [10], in CHO
and HeLa cells led to an altered appearance and function
of the ERC apparently reflecting a dominant-negative phe-
notype of this mutant [11]. Therefore, we constructed
GFP-tagged ∆EH mutants of each EHD protein, expressed
them in HeLa cells and assessed their localization relative
to the wild type versions. EHD1, 3 and 4 ∆EH-GFP
mutants accumulated in prominent vesicular structures of
varying sizes in the perinuclear region; these vesicular
structures were quite large in cells expressing EHD4 ∆EH-
GFP (Figure 5B). In contrast, the localization of the EHD2
∆EH-GFP was similar to that of the wild type EHD2-GFP
protein. These experiments complement our co-IP results
and suggest that localization and oligomerization of EHD
proteins may play an important role in their function.
Effects of EHD protein expression on Rab11 localization
Small GTPases of the Rab family have characteristic cellu-
lar distributions and are known to regulate membrane
traffic between different vesicular compartments [31] and
some have been implicated in the control of trafficking
within the endocytic pathway [32]. Of these, Rab11 is an
important marker of the ERC as well as a regulator of
transport through the ERC. Given the localization and
apparent regulatory role of EHD proteins in the ERC [11],
it appeared likely that these proteins may affect Rab11
function. We therefore assessed if EHD proteins colocal-
ized with Rab4, 5, 7, 9 and 11. For this purpose, we co-
expressed DsRed-tagged EHD proteins and GFP-tagged
Rab proteins in HeLa cells. We observed that EHD1, 3 and
4 showed partial colocalization with Rab11 while EHD2
and Rab11 did not colocalize (Figure 7). We could not
detect significant colocalization of EHD proteins with any
of the other Rab proteins tested (data not shown). The
incomplete colocalization of EHD1, 3 and 4 with Rab11
could reflect the dynamic state of vesicles on which these
proteins colocalize, with rapid fusion and budding events
allowing only partial colocalization at any given time
point. Therefore, we used live cell imaging of HeLa cells
co-transfected with EHD1-DsRed and Rab11-GFP to
assess if Rab11 and EHD proteins show dynamic colocal-
ization. Indeed, Rab11-positive (green) and EHD1-posi-
tive (red) vesicles were seen moving toward each other
with transient coalescence of the green and red fluores-
cence (seen as yellow) followed by rapid return to green
and red (Additional File 4). These results indicate that
Rab11 and EHD1 colocalization reflects a dynamic state.
We also examined the effect of expressing Myc-EHD ∆EH
mutants in HeLa cells on Rab11-GFP localization. While
none of the ∆EH mutants showed significant colocaliza-
tion with Rab11-GFP, the expression of EHD1 and 3 ∆EH
mutants resulted in a dramatic clustering of Rab11 in the
perinuclear area (Figure 8) which was not seen when
Rab11-GFP was co-transfected with wild type EHD pro-
teins (Figure 7). In contrast, EHD2 and 4 ∆EH mutants
did not produce noticeable alterations in Rab11 localiza-
tion. Thus, it appears that some EHD proteins might act
along with Rab11 in the same recycling pathway while
others might not, raising the possibility that different
EHD proteins may affect a common functional pathway
through distinct mechanisms.
Effect of EHD protein overexpression on transferrin 
trafficking
Exit of internalized transferrin out of the ERC has been
commonly used as an assay of ERC function [33-37].
Indeed, the first evidence for the role of EHD1 in mamma-
lian endocytic transport employed the ability of EHD1
G429R mutant to delay transferrin exit from the ERC [11].
Several recent studies have addressed the role of EHD1, 2
and 3 in regulating endocytic recycling but the picture
remains confusing due to the different transferrin receptor
recycling assays used [11,12,16,17]. Therefore, we com-
pared the effects of Myc-tagged wild type and Myc-EHD
∆EH proteins on transferrin recycling using a single assay
[38] so that any differences could be ascribed to the pro-Page 8 of 22
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ogy. HeLa cells transiently transfected with wild type or
∆EH mutants were allowed to internalize and accumulate
fluorescently-labelled transferrin in the ERC and then
chased with unlabeled transferrin for various time points.
In untransfected cells, essentially no cells showed residual
transferrin in the ERC at 60 min of chase (Figure 9A). Cells
transfected with wild-type EHD proteins showed a retar-
dation of transferrin exit from the ERC at 60 min of chase
(Figure 9B, black). Furthermore, EHD1 and 3 ∆EH pro-
duced an even stronger effect compared to their wild type
forms while the EHD4 mutant showed a milder effect
(Figure 9B, grey). In contrast, the effect of EHD2 mutant
was comparable to the wild type protein (Figure 9B).
Thus, overexpression of wild type as well as ∆EH mutants
appeared to perturb transferrin exit from the ERC. Nota-
bly, EHD2 behaved differently compared to other EHD
proteins in this assay. In contrast to a previous report, we
did not observe any defects of transferrin endocytosis in
EHD2-transfected cells [17] (Additional File 5). However,
as reported by Naslavsky et al., the block on transferrin
exit in our studies was quite modest [16].
Effect of siRNA-mediated knock-down of EHD proteins on 
transferrin recycling
In order to confirm the role of EHD proteins in transferrin
recycling, we used siRNA-mediated knock-down of EHD
proteins in HeLa cells and examined transferrin loading in
these cells. The specificity of the EHD knock-down is
shown in Additional File 6A. While EHD1, 2 and 4 siRNA
resulted in a moderate reduction (> 40%) in protein levels
(Additional File 6B), EHD3 knock-down using siRNA
sequences from Naslavsky et al. [16] showed only a mod-
est reduction in protein levels in our hands (~14%) but
showed an identical transferrin phenotype as published
for EHD3 (data not shown). As shown in Figure 10A,
EHD1 siRNA caused the accumulation of transferrin-con-
taining vesicles in the perinuclear area, in accordance with
the observations made previously using identical siRNA
sequences for EHD1 [16]. EHD2 siRNA induced a perinu-
clear transferrin accumulation phenotype similar to
EHD1 siRNA, while EHD4 siRNA induced a peripheral
transferrin accumulation phenotype, similar to the early
endosome phenotype published for EHD3 knock-down
[16] (Figure 10A).
Naslavasky et al. have previously reported the characteri-
zation of the compartment in which transferrin accumu-
lates following EHD3 knock-down [16]. These
investigators showed that early endosomal antigen 1 and
Rab5 were absent from the perinuclear region in EHD3
knock-down cells and instead these markers colocalized
with transferrin in enlarged peripheral early endosome
(EE) structures [16]. We transfected EHD4 knock-down
cells with Rab5-GFP and observed that Rab5-GFP was
Differential subcellular localization patterns of human EHD proteinsFigu  5
Differential subcellular localization patterns of 
human EHD proteins. (A) HeLa cells were transfected 
with C-terminal GFP-tagged EHD proteins for 24 h, fixed, 
mounted and scanned by a confocal microscope equipped 
with a 100× objective lens. Human EHD1-, 3- or 4-GFP are 
localized on tubular and vesicular structures in the perinu-
clear area, while EHD2-GFP is seen only in vesicular struc-
tures. Cells expressing EHD2 show microspikes; t, tubule; v, 
vesicle; m, microspikes. (B) HeLa cells were transfected with 
C-terminal GFP-tagged EHD ∆EH mutants for 24 h, fixed, 
mounted and scanned by a confocal microscope equipped 
with a 100× objective lens. Bar, 10 µm.Page 9 of 22
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Differential colocalization of GFP- and DsRed-tagged EHD proteins co-expressed in HeLa cellsFigu  6
Differential colocalization of GFP- and DsRed-tagged EHD proteins co-expressed in HeLa cells. HeLa cells were 
co-transfected with C-terminal GFP- (green) and DsRed-tagged (red) EHD proteins for 24 h, fixed, mounted and scanned by a 
confocal microscope equipped with a 100× objective lens. Colocalization is indicated when similar shaped structures appear 
yellow in the Merge (arrowheads). (A) EHD1-GFP, (B) EHD2-GFP, (C) EHD3-GFP, (D) EHD4-GFP co-transfected with each 
EHD-DsRed construct. Bar, 10 µm.
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Colocalization of EHD proteins with the endocytic recycling marker Rab11Figure 7
Colocalization of EHD proteins with the endocytic recycling marker Rab11. HeLa cells were co-transfected with 
Rab11-GFP (green) and EHD-DsRed (red) proteins for 24 h, fixed, mounted and scanned by a confocal microscope equipped 
with a 100× objective lens. Colocalization is indicated when similar shaped structures appear yellow in the Merge (arrow-
heads). Bar, 10 µm.
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Myc-EHD1 ∆EH and EHD3 ∆EH cause perinuclear clustering of Rab11-GFPFigure 8
Myc-EHD1 ∆EH and EHD3 ∆EH cause perinuclear clustering of Rab11-GFP. HeLa cells were co-transfected with 
Myc-EHD ∆EH proteins (red) and Rab11-GFP (green) for 24 h, fixed, stained with antibodies for Myc (9E10), mounted and 
scanned by a confocal microscope equipped with a 100× objective lens.
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Differential effects of wild type and ∆EH mutants of EHD1, 3, & 4 versus EHD2 on transferrin exit from the ERCFigu  9
Differential effects of wild type and ∆EH mutants of EHD1, 3, & 4 versus EHD2 on transferrin exit from the 
ERC. Untransfected HeLa cells or cells transiently transfected with Myc-EHD1 or Myc-EHD1 ∆EH were loaded with Transfer-
rin-coupled Alexa Fluor 488 (Tf, green) in internalization buffer at 37°C for 30 minutes 24 h after transfection, washed with 
ice-cold PBS and chased with serum-containing medium. The cells were fixed at various time points, stained with antibodies for 
Myc (9E10, red) and scanned on a confocal microscope. Similar experiments with EHD2-4 and EHD2-4 ∆EH are shown in 
Additional File 5. (B) Cells expressing Myc-EHD proteins (black bars) or Myc-EHD ∆EH proteins (grey bars) from a represent-
ative experiment were counted with respect to Tf retention after 60 min of chase. At least 200 cells were counted in each 
case.
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siRNA-mediated EHD protein knock-down effects on transferrin loading in HeLa cellsFigure 10
siRNA-mediated EHD protein knock-down effects on transferrin loading in HeLa cells. (A) HeLa cells were seeded 
on autoclaved glass coverslips in 6-well plates for 24 h followed by transfection of 200 pmol of double-stranded RNA oligonu-
cleotides with irrelevant or EHD siRNA for 48 h prior to transferrin loading. Cells were starved for 30 min in starvation media 
followed by Transferrin-coupled Alexa Fluor 594 in internalization buffer at 37°C for 15 min, washed with ice-cold PBS, fixed 
and scanned using a confocal microscope equipped with a 40× objective lens. The arrows in the EHD1 siRNA depict an ERC 
transferrin loading phenotype while the arrows in the EHD4 siRNA depict an EE phenotype. (B) Cells were transfected with 
siRNA for EHD proteins for 24 h and further transfected with Rab5-GFP or Rab11-GFP for an additional 24 h. Cells were then 
loaded with labeled transferrin for 15 min as described in Methods. Arrowheads point to colocalized structures. Bar, 10 µm. 
Data are representative of 3 individual experiments.
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transferrin in the periphery indicating that these are
indeed early endosomes (Figure 10B). Further, we colocal-
ized Rab11-GFP with the perinuclear vesicular structures
that accumulate transferrin in cells with EHD1 and 2
knock-down, indicating that they are the ERC (Figure
10B). In addition, we observed that cells with EHD1
siRNA showed clustering of Rab11-GFP in the perinuclear
area similar to cells overexpressing the EHD1 ∆EH mutant
(Figure 8). Furthermore, confirming results published by
the Caplan group, we noted that siRNA-mediated EHD3
knock-down resulted in the exclusion of Rab11 from the
ERC (data not shown) [16]; notably, EHD4 siRNA had a
similar effect on Rab11-GFP localization (Figure 10B).
These experiments confirm that EHD1 and 2 knock-down
result in the accumulation of transferrin in the ERC (des-
ignated the ERC phenotype) and EHD4 knock-down
results in the accumulation of transferrin in the EE com-
partment (designated the EE phenotype).
We also performed a transferrin recycling assay on these
cells where labelled transferrin was loaded and chased for
different time points. This assay allowed visualization of
the compartment in which transferrin was trapped as it
became demarcated during the course of the chase.
Knock-down of EHD1 resulted in retention of considera-
ble proportions of transferrin at 60 min of chase when
compared to the irrelevant siRNA control (Figure 11).
Cells with EHD4 knock-down retained less transferrin
during the chase when compared to EHD1 knock-down
yielding an intermediate phenotype while EHD2 knock-
down had little effect as compared to the irrelevant siRNA
control. Knock-down of EHD1 resulted in prolonged
retention of transferrin in a perinuclear compartment
while EHD4 knock-down led to retention in a peripheral
compartment (Figure 11). The transferrin loading and
recycling assays confirm that EHD1 and 2 function in the
ERC to regulate transferrin recycling, with EHD1 being a
dominant regulator, while EHD4 regulates transferrin exit
out of the EE. The lack of an effect on transferrin recycling
with EHD2 knock-down seen here is in agreement with
our results using the EHD2 ∆EH construct suggesting that
EHD2 functions at a location in the ERC where it exerts
minimal effects on transferrin recycling. Irrelevant siRNA
also seemed to affect transferrin recycling at 30 min but
was comparable to untransfected cells at 60 min of chase.
While it is not presently feasible to demonstrate concur-
rent knock-down of multiple EHD proteins in individual
cells while showing the transferrin phenotype, generation
of single and multiple EHD knock-out cells derived from
mice with targeted deletions of EHD proteins will allow
future analyses to address the authenticity of the pheno-
types seen here.
Discussion
To determine whether all EHD proteins had a functional
role in endocytic trafficking, we took advantage of the
availability of a C. elegans mutant in which the EHD
ortholog RME-1 was non-functional. We found that all
EHD proteins could rescue the basolateral trafficking
defect in the intestine of mutant worms and thus demon-
strate for the first time that all EHD proteins retain an
ancestral endocytic recycling function (Figure 1). Analysis
of multiple cell lines indicate that EHD1-4 proteins are co-
expressed in several human cell lines concurrently (Figure
2). Moreover, EHD proteins were found to be ubiqui-
tously expressed in the mouse tissues analyzed, albeit with
tissue-specific differences in protein levels (Figure 3).
Given that all four human EHD proteins function in our
C. elegans rescue experiments, their co-expression in mam-
malian cells (our studies and others [16]) suggests that
either mammalian EHD proteins play a functionally
redundant role in endocytic recycling or that they have
attained additional paralog-specific functions. As dis-
cussed below, our findings suggest that EHD proteins play
both redundant and specific roles.
Yeast two-hybrid studies as well as co-expression in mam-
malian cells indicate that EHD1 and 3 form homo- and
hetero-oligomers [15]; this process is mediated by a func-
tional P-loop and coiled-coil domain, and is independent
of the EH domain [9,16]. However, oligomerization of
EHD2 and 4 have not been previously examined using co-
IP analyses. In our analyses, we found that each EHD pro-
tein homo- and hetero-oligomerized, however, hetero-
oligomerization between EHD proteins was variable. For
example, EHD2 oligomerized weakly with EHD3 and 4
(Figure 4A). Consistent with observations that the EH
domain is not required for oligomerization [9,15,16], the
∆EH mutants oligomerized similar to wild type EHD pro-
teins (Figure 4B). Our results provide the first complete
analysis of the oligomerization capabilities of EHD pro-
teins in mammalian cells using a co-IP strategy. These
results broadly agree with the predicted coiled-coil struc-
ture deduced for each protein (Additional File 3). Co-IP of
endogenous EHD2 and 4 in mouse tissue lysates using
anti-EHD1 antibodies supports the likelihood that oli-
gomerization is physiologically relevant. Since EHD1 and
3 have been shown to bind to NPF-containing proteins in
an oligomerization-dependent (e.g. Rab11FIP2) and -
independent manner (e.g. Rabenosyn-5) [16], it is tempt-
ing to speculate that oligomerization might not only
influence membrane binding but also the selection of
protein interaction partners.
The results of our colocalization analyses in HeLa cells
mirrored the co-IP results: EHD1, 3 and 4 substantially
colocalized while EHD2 showed partial colocalization
with EHD4 and little colocalization with EHD1 and 3Page 15 of 22
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individual EHD proteins might change upon co-overex-
pression of other EHD proteins, this appears relatively
unlikely since EHD1, 3 and 4 did not appear to change
their pattern of localization when expressed with each
other; however, EHD4 structures did appear to change
upon co-expression with EHD2. In further support of the
differential endocytic localization of EHD proteins, we
observed that EHD1, 3 and 4 partially colocalized with
Rab11 while EHD2 showed minimal colocalization (Fig-
ure 7). Interestingly, even though EHD1, 3 and 4 colocal-
ized with Rab11, dramatic perinuclear clustering of
Rab11-GFP-positive vesicles only occurred upon overex-
pression of EHD1 ∆EH and 3 ∆EH mutants (not EHD2
∆EH and 4 ∆EH) suggesting that EHD1 and 3 may func-
tion in the same recycling pathway upstream of Rab11
(Figure 8). We were unable to detect any direct association
between EHD proteins and Rab11 upon co-IP analysis
(data not shown) similar to a previous report [16]. Knock-
down of EHD1 induced the perinuclear clustering of
Rab11-GFP similar to that of overexpression of EHD1
∆EH, however, we were unable to test whether this was
the case with EHD3 knock-down due to the inefficiency of
EHD3 knock-down (Additional File 6).
A recent study showed that EHD1 and 3 interact with
Rab11-FIP2, a Rab11 interacting protein, via EH-NPF
interactions, and recruit Rab11-FIP2 to EHD-containing
membranes in a P-loop and coiled-coil domain-depend-
ent manner; however, the authors were unable to show an
interaction between Rab11 and either EHD1 or 3 [16].
Rab11-FIP2 binds to both the GDP- and GTP-bound
siRNA-mediated EHD protein knock-down effects on transferrin recyclingFigure 11
siRNA-mediated EHD protein knock-down effects on transferrin recycling. Following EHD protein knock-down, 
transferrin loading was carried out essentially as in Figure 10 except that Transferrin-coupled Alexa Fluor 488 was loaded for 
30 min. Following transferrin loading, cells were washed with ice-cold PBS, changed to serum-containing media and allowed to 
recycle transferrin at 37°C for various time points. The cells were fixed and scanned using a confocal microscope equipped 
with a 40× objective lens. Knock-down cells retaining more transferrin than irrelevant controls at 60 min of chase were consid-
ered to be delayed in recycling transferrin. Irrelevant siRNA mildly affected transferrin recycling at 30 min of chase as com-
pared to mock. Bar, 10 µm.Page 16 of 22
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membrane [39,40]. We hypothesize that EHD1 and 3
∆EH mutants might interfere with their wild type protein
function since they might not bind to NPF motifs on
Rab11-FIP2. Since oligomerization of EHD1 and 3 was
shown to be required for Rab11-FIP2 binding [16], the
lower propensity for EHD2 and 4 to hetero-oligomerize
might spare Rab11-FIP2 function leading to the inability
of EHD2 and 4 ∆EH mutants to induce Rab11 clustering.
It will be of great interest to assess whether EHD2 and 4
interact with Rab11-FIP2.
Our analyses of the impact of EHD proteins on transferrin
exit from the ERC revealed that overexpression of wild
type EHD proteins retarded this process (Figure 9B,
black). While paradoxical, this finding is not unprece-
dented, as overexpression of other proteins involved in
endocytic traffic, such as Rififylin, the RING finger and
FYVE-like domain ERC protein, also led to a block in
transferrin recycling [33] perhaps due to disruption of
functional protein complexes and/or sequestration of
effector proteins. Overexpression of EHD1, 3 and 4 ∆EH
mutants further increased the transferrin exit block while
that of EHD2 ∆EH did not (Figure 9B, grey).
The role of EHD proteins in transferrin trafficking was fur-
ther clarified by the use of siRNA-mediated EHD knock-
down. Transferrin loading and recycling experiments in
siRNA-transfected cells revealed that all EHD proteins reg-
ulate transferrin trafficking (Figure 10A–C, Figure 11), in
agreement with the results of the dominant-negative
mutant approach. These experiments together with pub-
lished studies on EHD3 [16] allow the classification of
EHD proteins into two groups based on their effects on
transferrin: EHD1 and 2 appear to regulate exit of transfer-
rin out of the ERC and hence are ERC regulators (Figure
10A–C, Figure 11) while EHD3 [16] and 4 function in the
EE and hence are EE regulators. Our results in this regard
confirm the studies of the Caplan group using EHD1 and
3 knock-down but extend these to EHD2 and 4.
Our biochemical and functional analyses of EHD proteins
together with recent studies from other groups lead to a
speculative model depicted in Figure 12. The four EHD
proteins are differentially distributed within the recycling
pathway with EHD3 and 4 functional in the EE and EHD1
and 2 in the ERC. At these locations, they could interact
through their conserved EH domains with either similar
or diverse NPF-containing partners. Distinct oligomers,
formed as a result of preferential oligomerization through
coiled-coils, could also mediate the recruitment of differ-
ent EH domain binding partners in each compartment
conferring a degree of selectivity to EHD function. For
example, the presence of an apparently non-redundant
EHD (EHD2) in the recycling endosome might help direct
traffic into Rab11-dependent and -independent pathways
and increase the versatility of recycling at the ERC. Further
biochemical, cell biological and genetic studies on this
conserved family of proteins will lead to an improved
understanding of the endocytic recycling pathway.
Conclusion
Overall, our biochemical and functional analyses of the
human EHD proteins, members of a newly identified EH
domain-containing protein family, indicate that they
share an ancestral function of regulating endocytic recy-
cling. Studies using dominant negative mutants and
siRNA unravelled some important differences between
the members, EHD1 and 2 regulate recycling at the ERC
while EHD3 and 4 regulate EE to ERC transport. Overall,
EHD2 appears to be the most divergent member with
respect to localization and functions that we tested, while
EHD4 seemed to be intermediate between EHD1/3 and
EHD2. As mentioned previously, EHD2 and 4 have been
predominantly studied in specific cell types such as adi-
pocytes and pheochromocytoma cells, respectively. How-
ever, all four EHD proteins have not been compared
concurrently in a single cell type. The contrast between the
common ancestral endocytic trafficking function indi-
Model of EHD-dependent and EHD-independent trafficking fr m the early and recycling endosomesFigure 12
Model of EHD-dependent and EHD-independent 
trafficking from the early and recycling endosomes. 
Membrane-bound receptors and their cargo (such as the 
transferrin receptor and transferrin, respectively) that are 
destined for recycling to the cell surface following endocyto-
sis can be internalized into the early endosome (EE) com-
partments, transferred to the endocytic recycling 
compartment (ERC) before returning to the cell surface. 
From siRNA-mediated depletion of EHD proteins and trans-
ferrin loading and recycling experiments here and elsewhere 
(Naslavsky et al. 2006) [16], EHD3 and 4 are hypothesized to 
regulate transferrin trafficking from the EE to the ERC while 
EHD1 and 2 regulate transferrin exit from the ERC. Proteins 
such as Rabenosyn5 and Rab11-FIP2 associate with EHD pro-
teins through EH-NPF interactions and facilitate endosomal 
recycling.Page 17 of 22
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EHD proteins revealed by studies in HeLa cells suggest
that EHD proteins have functionally diversified during
their recent evolution to match the versatility demanded
by the complexity of endocytic traffic in mammalian cells.
Further, comparative biochemical and cell biological
studies of the EHD protein family between mammalian
and non-mammalian systems should, therefore, facilitate
our understanding of these conserved endocytic regula-
tors, as well as provide new insights into the functional
diversity of mammalian endocytic compartments. EHD1
knock-out mice have been generated recently and do not
display any abnormality other than slower transferrin
recycling in isolated mouse embryonic fibroblasts; possi-
bly, indicating the overall redundancy of the EHD protein
family [41]. Availability of single and multiple knock-out
mice should further help to delineate EHD function along
various steps in the recycling pathway.
Methods
Expression constructs
Sequences encoding human EHD proteins were PCR
amplified from clones (ImageClone 5229002 for EHD1,
4908085 for EHD2, 5459130 for EHD3 (ATCC) and Ulti-
mate ORF clone IOH6327 for EHD4 (Invitrogen)) using
the primers listed in Additional File 7. The PCR products
were cloned into pENTR/SD/D-TOPO vector following
the manufacturer's instructions (Invitrogen) and
sequences of correct clones were verified. The inserts were
then transferred into pcDNA-pDEST47 (Invitrogen) vec-
tor using an LR Clonase reaction for CMV promoter-
driven expression as C-terminal GFP-fusion proteins.
GFP-tagged ∆EH deletion mutants were generated using
reverse PCR primers excluding the C-terminal EH domain,
the sizes of the mutant proteins with respect to number of
amino acids were: EHD1 ∆EH (1–435), EHD2 ∆EH (1–
439), EHD3 ∆EH (1–434) and EHD4 ∆EH (1–437); these
mutants also contain an N-terminal Myc-tag. Myc-tagged
wild type and ∆EH deletion mutants were also generated
using the PCR with the inclusion of sequences for the
Myc-tag in the forward primers followed by LR-mediated
transfer into pcDNA-6.2/cLumio-DEST vector. While
Myc-tagged proteins proved very useful in biochemical
analyses, anti-Myc immunostaining was not fully compa-
rable to corresponding EHD-GFP fluorescence patterns.
To independently confirm the EHD-GFP localization pat-
terns, DsRed-Monomer-tagged wild type EHD constructs
were generated specifically for use in colocalization stud-
ies using forward primers with an Xho I site and reverse
primers with a Hind III site, and cloned into Xho I-Hind
III cut DsRed-Monomer-N1 vector (Clontech). All DsRed
constructs used in this study were DsRed-Monomer and
will be referred to as DsRed.
The EHD3 ImageClone was derived from a neuroblast-
oma and was found to lack a cytosine (C) at position 1552
of the ORF predicted by the Unigene sequence (ACCES-
SION: NM_014600), which we confirmed using the
reverse transcription-PCR cloning and sequencing of
EHD3 mRNA from 20 separate clones from four fibrob-
last and mammary epithelial cell lines. Therefore, the
missing C in the ImageClone-derived EHD3 was replaced
by site-directed mutagenesis. Primers used in the study are
listed in Additional File 7.
The Rab5-GFP and Rab11-GFP constructs in EGFPN1 vec-
tor were provided by Dr. Victor Hsu (Brigham and
Women's Hospital, Harvard Medical School, Boston,
MA). The GFP-MTMR3 construct was provided by Dr.
Michael Clague (University of Liverpool, Liverpool, UK).
The Myc-SNX1 construct was provided by Dr. JoAnn Trejo
(UNC School of Medicine, Chapel Hill, North Carolina).
Cell culture
HeLa cells (obtained from Dr. Victor Hsu) and human
embryonic kidney (HEK) 293T cells were grown in Dul-
becco's Modified Eagle Medium (DMEM) containing 5%
fetal bovine serum (FBS, Hyclone Inc., Logan, UT), 20
mM HEPES, pH 7.35, 1 mM sodium pyruvate, 1 mM each
of nonessential amino acids, 100 units/ml penicillin and
100 µg/ml streptomycin (all supplements from Invitro-
gen).
Primary (76N) and immortalized (16A5, MCF10A)
human mammary epithelial cell strains were grown in
DFCI-1 medium as described [42]. Human Breast carci-
noma cell line T47D, cervical carcinoma cell line SiHa and
osteosarcoma cell line U2OS were cultured in alpha-min-
imal essential medium (Invitrogen) supplemented with
5% fetal calf serum (Hyclone Inc., Logan, UT).
Gene knock-down by small interfering RNA (siRNA)
Small interfering RNA (siRNA) oligonucleotides (synthe-
sized by Dharmacon, Lafayette, CO) were transfected
using Oligofectamine (Invitrogen) following the manu-
facturer's instructions. Demonstrable knock-down of pro-
tein expression was seen 48 h after transfection. siRNA
sequences targeting EHD1 and EHD3 were as in Caplan et
al. 2005 (EHD1, 5'-gaa aga gat gcc caa tgt c, bases 945–
963; EHD3, 5'-act gga cat ctc tga tga g, bases 945–963)
[16]. siRNA sequences targeting EHD2 and EHD4 (EHD2,
5'-gtc tac atc ggc tcc ttc t, bases 754–772; EHD4, 5'-tgg agg
acg ccg act tcg a, bases 158–176) were generated using the
SFold algorithm [43]. An irrelevant siRNA control
(siCONTROL Non-Targeting siRNA, Cat. #D-001210-01-
20) was purchased from Dharmacon (Lafayette, CO).Page 18 of 22
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Rabbit polyclonal antibodies were raised against synthetic
peptides coupled through an N-terminal cysteine to Key-
hole Limpet Hemocyanin (KLH) (CVSKDARRKKEPELF
for EHD1, CSKRRHKGSAE for EHD2,
CNLKRMQDQLQAQ for EHD3, and CSHRKSLPKAD for
EHD4) using a commercial vendor (Animal Pharm Serv-
ices, Inc., Healdsburg, CA). Primary immunization with
150 µg of KLH-peptide in Freund's Complete Adjuvant
was followed by three booster injections of 100 µg in Fre-
und's Incomplete Adjuvant. The monoclonal antibody
9E10 (anti-Myc) [44] was purified from serum-free cul-
ture supernatants using Protein G Sepharose 4 Fast Flow
beads (Amersham Biosciences, Piscataway, NJ). Rabbit
anti-green fluorescent protein (anti-GFP, sc-8334) was
from Santa Cruz Biotechnology (Santa Cruz, CA).
For Western blotting, cell lysates were prepared in Lae-
mmli SDS-PAGE sample buffer, and protein concentra-
tion was determined using the Bio-Rad Dc Protein Assay
(Bio-Rad Laboratories, Hercules, CA) with bovine serum
albumin as standard. Aliquots of 100 µg protein lysate
were separated by SDS-PAGE, transferred to polyvinyli-
dene difluoride (PVDF) membranes (PerkinElmer, Bos-
ton, MA) and immunoblotted with 1:2000 dilutions of
the indicated antisera, followed by 1:10,000 dilution of
horseradish peroxidase (HRP)-conjugated protein A
(Cappel/Organon Teknika Corp., West Chester, PA), as
described [45]. Signals were detected using Western Light-
ning Chemiluminescence Reagent Plus (PerkinElmer,
Boston, MA) and Kodak X-Omat Blue XB-1 film (Perk-
inElmer, Boston, MA). Figures were prepared by direct
scanning of films with a Hewlett Packard Scanjet 7400c
scanner and Photoshop 6.0 software.
Preparation of mouse tissue lysates
Mice (18 week-old male and female C57BL/6J) were sac-
rificed and organs were dissected (brain, heart, lung liver,
spleen, kidney, intestine, and testes (male) or mammary
gland (female)), washed thoroughly in PBS, chopped into
fine pieces, and rocked at 4°C in tissue lysis buffer (50
mM Tris-HCl (pH7.5), 150 mM NaCl, 1 mM EDTA, 2.5
mM EGTA, 1 mM DTT, 0.1% Tween-20, 10% glycerol, 2
mM Na3VO4, 20 mM NaF, 1 mM PMSF) overnight. 100 µg
of aliquots of lysate protein were separated using 8% SDS-
PAGE and Western blotted as described above.
Co-immunoprecipitations
HEK 293T cells were transfected with 2.5 µg each of Myc-
EHD and EHD-GFP DNA constructs using a modified ver-
sion of the calcium phosphate method [46], grown for
26–30 h, lysed with cold lysis buffer (1% Triton X-100,
150 mM NaCl, 50 mM Tris-HCl, pH 7.6) supplemented
with 0.1 mM phenylmethylsulfonyl fluoride, 1 mM
sodium orthovanadate, and 10 mM sodium fluoride [47],
and rocked at 4°C overnight or 1–2 hours for Myc-EHD
and Myc-EHD ∆EH immunoprecipitations, respectively.
Immunoprecipitations were carried out as described pre-
viously [48,49] using 1 mg aliquots of protein lysate, 3 µg
of anti-Myc antibody and 20 µl of Protein G Sepharose
beads. Beads were washed five times, and bound proteins
were eluted in Laemmli sample buffer with 2-mercap-
toethanol and resolved by 8% SDS-PAGE followed by
immunoblotting. Myc-tagged proteins were detected with
mouse-anti-Myc 9E10 at 500 ng/ml and rabbit anti-
mouse IgG (H+L)-HRP conjugate (Zymed, San Fransisco,
CA) at 1:25,000. GFP-tagged proteins were detected with
rabbit anti-GFP (Santa Cruz Biotechnology, Santa Cruz,
CA) at 200 ng/ml followed by Protein A-HRP (Zymed,
San Fransisco, CA) at 1:25,000. Chemiluminescence
detection was as described above.
Transfection, immunofluorescence and confocal 
microscopy
HeLa cells were grown on 12-mm diameter glass cover-
slips (Fisher Scientific, Pittsburgh, PA) for 1 day, trans-
fected using the calcium phosphate co-precipitation
method with the desired plasmids for 24 h, rinsed with
phosphate-buffered saline (PBS) and fixed with 4% para-
formaldehyde in PBS at 4°C o Cvernight. The cells were
rinsed with PBS, followed by the addition of permeabili-
zation and blocking buffer (PBS containing 5% FBS and
0.05% saponin from Quillaja bark (Sigma, St. Louis, MO)
at 25°C for 30 min. For anti-Myc staining, cells were incu-
bated with mouse-anti-Myc (0.5 µg/ml) at 25°C for 1 h.
After rinsing with wash buffer (0.05% saponin in PBS),
cells were incubated with Alexa Fluor 594-conjugated goat
anti-mouse IgG (Molecular Probes, Eugene, OR, A11005)
at 25°C for 1 h. The cells were washed extensively with
wash buffer and mounted on glass slides using
Vectasheild with DAPI for nuclear staining (Vector Labo-
ratories, Burlingame, CA). Fluorescently-stained cells were
scanned using a Nikon Eclipse 80i confocal microscope
equipped with a Nikon D-eclipse C1 scanning head
(Nikon) and analyzed using the EZ-C12.10 software.
Live cell imaging
Live cell video microscopy was performed on transfected
HeLa cells grown on Poly-D-Lysine-coated 35-mm cover-
slip bottom dishes (BD Biocoat Cell Environments). Dur-
ing imaging, cells were immersed in CO2-independent
medium (Life Technologies, Grand Island, NY). The cells
were imaged every 5 seconds for 7 minutes using a 100×
oil immersion objective on an inverted microscope
(Model TE2000-U; Nikon) equipped with a charge-cou-
pled device camera controlled by Metamorph software
(Universal Imaging Corp.). Image control and post-cap-
ture image analysis were performed using MetaMorph
software.Page 19 of 22
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Wild type or Myc-EHD ∆EH-transfected HeLa cells were
loaded with Alexa Fluor 488-labeled transferrin (Molecu-
lar Probes, Eugene, OR, T-13342) at 10 µg/ml in internal-
ization media (DMEM, 10 mM HEPES pH 7.4, 0.1% BSA)
at 37°C for 30 min, rinsed with ice-cold PBS followed by
transferrin chase by incubation at 37°C in regular serum-
containing media [38]. At the indicated time points, cells
were washed twice and fixed with 4% paraformaldehyde,
stained with anti-Myc antibody and mounted as above,
followed by image acquisition. For colocalization of
transferrin with Rab5 and Rab11 in siRNA-transfected
cells, cells were transfected with Rab5 and Rab11-GFP 24
h after siRNA transfection using the FuGene 6 reagent
(Roche Diagnostics, Indianapolis, IN). After 24 hours, the
cells were loaded with transferrin as described above,
fixed in 4% paraformaldehyde and mounted on glass
slides using Vectasheild with DAPI for nuclear staining
(Vector Laboratories, Burlingame, CA). Confocal analyses
were performed with Zeiss inverted LSM510 confocal
microscopy system.
C. elegans strains, culture conditions, and rme-1(b1045) 
rescue experiments
C. elegans worms were cultured at 22°C under standard
growth conditions [50]. Strains used in this study were:
Bristol strain N2 (wild type) and rme-1(b1045) with a
mutation in the EHD ortholog [10]. To test whether
human EHD proteins could rescue the vacuolated intes-
tine phenotype of rme-1 worms, full length human EHD
cDNAs were expressed downstream of a worm intestine-
specific Vha-6 promoter [30] in pENtr vector containing
the SL2-gfp operon cassette [51] (details of plasmids avail-
able upon request). The rescue constructs (50 ng/µl) were
co-injected with a GFP marker (myo::gfp at 100 ng/µl)
into the gonads of hermaphrodite rme-1(b1045) worms
using standard methodology [52]. The intestinal vacuoles
were counted in three independent lines of transgenic
adult worms (grown 3–4 days) expressing GFP in intesti-
nal cells. At least 25 worms were counted for each inde-
pendent line. The basolateral endocytosis assay of the
intestinal vacuoles was performed in adult hermaphro-
dites by microinjection of 1 mg/mL Texas-Red BSA into
the pseudocoelom as described [10].
Abbreviations
1The abbreviations used are: co-immunoprecipitation =
co-IP, EE = early endosome, Eps15 = epidermal growth
factor receptor pathway substrate 15, EH = Eps15 Homol-
ogy, EHD protein = EH domain-containing protein, ERC
= endocytic recycling compartment, NPF = Asn-Pro-Phe,
RME-1 = receptor-mediated endocytosis-1, P-loop = phos-
phate-binding loop, Rab11-FIP2 = Rab11-Family Interact-
ing Protein 2, Tf = transferrin, TR-BSA = Texas Red-BSA,
siRNA = small interfering RNA.
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Additional File 1
Determination of the specificity of EHD peptide antisera. HEK 293FT 
cells in 100-mm tissue culture dishes were transiently transfected with 
DNA encoding a single EHD-GFP (6 µg) construct. Cell lysates were pre-
pared as in Methods. Aliquots of 100 µg were loaded onto an 8% SDS-
PAGE gel, transferred to a PVDF membrane, and immunoblotted with 
specific EHD anti-sera as shown. Relative molecular weight (MW) mark-
ers are indicated in kiloDaltons (kD).




Western blot of whole cell lysates of GFP-tagged EHD proteins used 
in Figure 4. Aliquots of 100 µg of the lysates used for co-immunoprecipi-
tations (co-IP) in Figure 4 were run on the same gel as those in Figure 4, 
transferred to PVDF membranes, and immunoblotted in parallel with 
anti-GFP antibodies. (A) Whole cell lysates for Figure 4A. (B) Whole cell 
lysates for Figure 4B. (C) Control IPs using 1 mg of whole cell lysates 
(WCL) and co-IPs were carried out as described in Methods using GFP-
myotubularian-related protein 3 (MTMR3), Myc-sorting nexin 1 
(SNX1), Myc-EHD1 and EHD1-GFP. Lanes 1–3: WCL, 100 µg. Lanes 
4–6: 1 mg IP. Relative molecular weight (MW) markers are indicated in 
kiloDaltons (kD). The heavy chain of the mouse IgG (IgH) is also shown 
indicating similar levels of antibody (anti-Myc, 9e10) were used for the 
IP.




Coiled-coil prediction plots of EHD proteins using COILS. Primary 
amino acid sequences of EHD1-4 were subjected to analysis using the 
COILS program [53] to predict the probability of the protein to adopt a 
coiled-coil conformation using a 28 residue scan.
Click here for file
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